CAMBRIAN BIOWORKS SECURES $1.45 MILLION IN SEED ROUND
Bengaluru-based biotechnology firm, Cambrian Bioworks, has made a significant leap forward in its growth journey by securing $1.45 million in a seed round of funding. The investment, led by the Irani family office, marks a crucial milestone for the company as it looks to strengthen its foothold in the evolving landscape of automated molecular diagnostics.
Key Highlights:
- Cambrian Bioworks, founded by Vaibhav Hegde, Rohit Asil, and Raghav Sridhar, has secured $1.45 million in a seed round led by the Irani family office.
- The funding will be utilized to accelerate the development of the company’s automated molecular diagnostics platforms, including the recent launch of Manta, its nucleic acid extraction platform.
- The proceeds will also support R&D efforts, team expansion, and forays into international markets.
- Cambrian Bioworks’ diagnostic platforms have applications in oncology, genomics, rare disease testing, and AMR detection, underscoring the company’s commitment to addressing pressing healthcare challenges.
Founder-led Investments on the Rise:
The trend of founders investing in their own startups has witnessed a surge in recent times, with prominent examples including Byju’s, OYO, and BluSmart. This trend continues, with the founders of Yubi and Ather Energy also joining the ranks of Moonwalking veterans who walked the same path.
